Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hepato Cellular Carcinoma × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 99 Breast Neoplasms 88 Prostatic Neoplasms 65 Multiple Myeloma 58 Neoplasms 56 Neoplasm Metastasis 52 Lung Neoplasms 47 Colorectal Neoplasms 46 Leukemia, Myeloid, Acute 44 Squamous Cell Carcinoma of Head and Neck 43 Carcinoma, Hepatocellular 35 Ovarian Neoplasms 34 Melanoma 34 Lymphoma 32 Triple Negative Breast Neoplasms 29 Carcinoma, Renal Cell 29 Sarcoma 28 Glioma 28 Lymphoma, Large B-Cell, Diffuse 27 Leukemia, Lymphocytic, Chronic, B-Cell 27 Pancreatic Neoplasms 26 Brain Neoplasms 26 Recurrence 25 Stomach Neoplasms 24 Lymphoma, Non-Hodgkin 24 Hematologic Neoplasms 24 Head and Neck Neoplasms 24 Endometrial Neoplasms 24 Urinary Bladder Neoplasms 23 Small Cell Lung Carcinoma 22

Interventions

tremelimumab 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07489976 2026-03-27

IIT2025-03-YANG-LIFT-HCC

Cedars-Sinai Medical Center

Phase 2 Recruiting

Hepato Cellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡